<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Basel Medical Group Ltd — News on 6ix</title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares</link>
<description>Latest news and press releases for Basel Medical Group Ltd on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 24 Mar 2026 10:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/basel-medical-group-ltd-ordinary-shares" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68354e5278dffbe2df0e6508.webp</url>
<title>Basel Medical Group Ltd</title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares</link>
</image>
<item>
<title>Compliance With Nasdaq Periodic Filing Requirement</title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/compliance-with-nasdaq-periodic-filing-requirement</link>
<guid isPermaLink="true">https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/compliance-with-nasdaq-periodic-filing-requirement</guid>
<pubDate>Tue, 24 Mar 2026 10:30:00 GMT</pubDate>
<description>Singapore, March 24, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today announced that it has received notification from Nasdaq that based on the Company’s amended annual report on Form 20-F for the fiscal year of 2025, which was filed with the SEC on March 13, 2026, Nasdaq Staff has now determined that the Company has complied with the periodic filing requirement for The Nasdaq Stock Market under Listing Rule 5250(c)(1) (the “Periodic Filing Rule”). Accordingl</description>
</item>
<item>
<title>Receipt of Delinquency Notification from Nasdaq</title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/receipt-delinquency-notification-nasdaq-213000590</link>
<guid isPermaLink="true">https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/receipt-delinquency-notification-nasdaq-213000590</guid>
<pubDate>Fri, 23 Jan 2026 21:30:00 GMT</pubDate>
<description>Singapore, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), today announced that it has received notification from Nasdaq that based on the closing bid price of the Company’s shares for the last 30 consecutive business days, the Company no longer meets the requirements under Nasdaq’s Listing Rules (the “Rules”) for listed securities to maintain a minimum bid price of $1 per share. The Rules provide the Company a compliance period of 180 calendar days in w</description>
</item>
<item>
<title>Basel Medical Group Putting On Hold On The Acquisition of BTC Digital Asset</title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-putting-on-hold-on-the-acquisition-of-btc-digital-asset</link>
<guid isPermaLink="true">https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-putting-on-hold-on-the-acquisition-of-btc-digital-asset</guid>
<pubDate>Thu, 17 Jul 2025 04:00:00 GMT</pubDate>
<description>Singapore, July 17, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that it is putting on hold on the</description>
</item>
<item>
<title>Basel Medical Obtains Waiver of Lock-Up for Potential Strategic Fund Raising</title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-obtains-waiver-lock-201500482</link>
<guid isPermaLink="true">https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-obtains-waiver-lock-201500482</guid>
<pubDate>Thu, 26 Jun 2025 20:15:00 GMT</pubDate>
<description>Singapore, June 26, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), today announced that Cathay Securities, Inc., as the representative of the several underwriters of the Company’s initial public offering, has granted its consent on June 23, 2025 to the lock-up provision in the underwriting agreement dated February 24, 2025, permitting (i) a public offering or private placement of new securities of the Company, and (ii) the filing with the U.S. Securities and Exc</description>
</item>
<item>
<title>Basel Medical Group Ltd Reaffirms Strong Financial Position Amid Market Volatility</title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-ltd-reaffirms-141100120</link>
<guid isPermaLink="true">https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-ltd-reaffirms-141100120</guid>
<pubDate>Thu, 29 May 2025 14:11:00 GMT</pubDate>
<description>Singapore, May 29, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today reaffirmed the strength of its underlying financial performance and strategic outlook, despite recent volatility in its share price. Speaking on behalf of the Board and management team, BMGL’s Chief Executive Officer, Dr Darren Chhoa stated, “While recent movements in our share price may raise questions, I want to assure our shareholders and stakeholders that the fundamentals of BMGL remain</description>
</item>
<item>
<title>Basel Medical Group Ltd Enters into US$ 1.0 Billion Bitcoin (BTC) Purchase Agreement</title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-ltd-enters-into-usdollar-10-billion-bitcoin-btc-purchase-agreement</link>
<guid isPermaLink="true">https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-ltd-enters-into-usdollar-10-billion-bitcoin-btc-purchase-agreement</guid>
<pubDate>Thu, 22 May 2025 04:00:00 GMT</pubDate>
<description>Singapore, May 22, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that it has entered into a purchase</description>
</item>
<item>
<title>Basel Medical Group Subsidiary Awarded S$375 Million Contract to Supply Healthcare Products; Group to Enhance AI-Powered Healthcare Supply Chain Capabilities</title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-subsidiary-awarded-132000437</link>
<guid isPermaLink="true">https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-subsidiary-awarded-132000437</guid>
<pubDate>Tue, 20 May 2025 13:20:00 GMT</pubDate>
<description>Singapore, May 20, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that its subsidiary has been awarded a significant contract worth S$375 million by Pancare Technology International (HK) Limited to supply essential healthcare products in Asia-Pacific over the next five years until October 31, 2029. This milestone underscores the Company’s commitment to delivering high-quality medical solutions and strengthening its global presence in the healthc</description>
</item>
<item>
<title>Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia</title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-completes-acquisition-041500166</link>
<guid isPermaLink="true">https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-completes-acquisition-041500166</guid>
<pubDate>Wed, 30 Apr 2025 04:15:00 GMT</pubDate>
<description>Singapore , April 30, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL), today announced the closing of the acquisition of Bethesda Medical Pte. Ltd., a leading Singapore-based healthcare provider specializing in diagnostic imaging and outpatient care. The acquisition marks a significant step in Basel Medical Group’s strategic expansion in Singapore and the broader Southeast Asian healthcare market. About Bethesda Medical Pte. Ltd. Bethesda Medical started its first medical establi</description>
</item>
<item>
<title>Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia </title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-completes-acquisition-of-bethesda-medical-to-strengthen-healthcare-ecosystem-in-singapore-and-southeast-asia</link>
<guid isPermaLink="true">https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-completes-acquisition-of-bethesda-medical-to-strengthen-healthcare-ecosystem-in-singapore-and-southeast-asia</guid>
<pubDate>Wed, 30 Apr 2025 04:00:00 GMT</pubDate>
<description>Singapore , April 30, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL), today announced the closing of the acquisition of Bethesda Medical Pte.</description>
</item>
<item>
<title>Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia</title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-signs-agreement-063000907</link>
<guid isPermaLink="true">https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-signs-agreement-063000907</guid>
<pubDate>Fri, 11 Apr 2025 06:30:00 GMT</pubDate>
<description>Singapore, April 11, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL), today announced the signing of a definitive agreement by its subsidiary Basel Medical Group Pte. Ltd. to acquire Bethesda Medical Pte. Ltd., a leading Singapore-based healthcare provider specializing in diagnostic imaging and outpatient care. The agreement marks a significant step in Basel Medical Group’s strategic expansion in Singapore and the broader Southeast Asian healthcare market. The completion of the a</description>
</item>
<item>
<title>Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia </title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-signs-agreement-to-acquire-bethesda-medical-to-strengthen-healthcare-ecosystem-in-singapore-and-southeast-asia</link>
<guid isPermaLink="true">https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-signs-agreement-to-acquire-bethesda-medical-to-strengthen-healthcare-ecosystem-in-singapore-and-southeast-asia</guid>
<pubDate>Fri, 11 Apr 2025 04:00:00 GMT</pubDate>
<description>Singapore, April 11, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL), today announced the signing of a definitive agreement by its subsidiary</description>
</item>
<item>
<title>Basel Medical Group Ltd Announces Exercise of Overallotment Option</title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-ltd-announces-201000525</link>
<guid isPermaLink="true">https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-ltd-announces-201000525</guid>
<pubDate>Wed, 19 Mar 2025 20:10:00 GMT</pubDate>
<description>Singapore, March 19, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (the “Company”) (Nasdaq: BMGL), a Singapore-based clinical provider of general and subspecialized orthopedic and trauma services, sports medicine and surgery, orthopedic procedures, as well as neurosurgical treatments, today announced the full exercise of the overallotment option by the representative of the underwriters of its initial public offering to purchase an additional 330,750 ordinary shares at a price of US$4.00 per</description>
</item>
<item>
<title>Basel Medical Group Ltd Announces Closing of US$8,820,000 Initial Public Offering</title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-ltd-announces-090000492</link>
<guid isPermaLink="true">https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-ltd-announces-090000492</guid>
<pubDate>Mon, 03 Mar 2025 09:00:00 GMT</pubDate>
<description>Singapore, March 03, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (the “Company”) (Nasdaq: BMGL), a Singapore-based clinical provider of general and subspecialized orthopedic and trauma services, sports medicine and surgery, orthopedic procedures, as well as neurosurgical treatments, today announced the closing of its initial public offering of 2,205,000 ordinary shares at a public offering price of US$4.00 per share. The shares commenced trading on the Nasdaq Capital Market on February 25,</description>
</item>
<item>
<title>Basel Medical Group Ltd Prices US$8,820,000 Initial Public Offering</title>
<link>https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-ltd-prices-220800603</link>
<guid isPermaLink="true">https://6ix.com/company/basel-medical-group-ltd-ordinary-shares/news/basel-medical-group-ltd-prices-220800603</guid>
<pubDate>Tue, 25 Feb 2025 22:08:00 GMT</pubDate>
<description>Singapore, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (the “Company”) (Nasdaq: BMGL), a Singapore-based clinical provider of general and subspecialized orthopedic and trauma services, sports medicine and surgery, orthopedic procedures, as well as neurosurgical treatments, today announced the pricing of its initial public offering of 2,205,000 ordinary shares at a public offering price of US$4.00 per share. The shares are expected to commence trading on the Nasdaq Capital Market on</description>
</item>
</channel>
</rss>